Health Care & Life Sciences » Pharmaceuticals | Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,552.10
676.10
294.40
3,204.10
9,184
Other Current Assets
-
60.00
598.50
220.20
57.70
Total Current Assets
1,552.10
736.10
892.80
3,424.40
10,060.10
Net Property, Plant & Equipment
-
-
3.70
3.20
1.50
Intangible Assets
5.40
5.40
20,986.80
20,986.80
20,986.80
Other Assets
-
-
67.00
2.20
2.20
Total Assets
1,557.50
741.50
21,950.30
24,416.60
31,050.50
ST Debt & Current Portion LT Debt
600.00
-
673.00
173.00
Accounts Payable
-
-
-
602.40
Other Current Liabilities
1,699.40
1,376.80
4,511.00
1,693.80
Total Current Liabilities
2,299.40
1,376.80
5,184.00
2,469.20
Total Liabilities
2,299.40
1,376.80
5,184.00
2,469.20
Common Equity (Total)
741.90
635.20
16,766.40
21,947.40
Total Shareholders' Equity
741.90
635.20
16,766.40
21,947.40
Total Equity
741.90
635.20
16,766.40
21,947.40
Liabilities & Shareholders' Equity
1,557.50
741.50
21,950.30
24,416.60

About Citius Pharmaceuticals

View Profile
Address
11 Commerce Drive
Cranford New Jersey 07016
United States
Employees -
Website http://www.citiuspharma.com
Updated 07/08/2019
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. Its products include Mino-Lok and hydrocortisone-lidocaine. The company was founded on September 09, 2010 and is headquartered in Cranford, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.